PODD
Insulet Corporation
PODD's fundamentals are strong and it looks cheap: trading at 24x earnings, less than half its usual 148x. Analysts expect strong earnings growth, though they disagree widely on how much.
PODD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
PODD's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
PODD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 20x | $149 | — |
| Current | 24x | $149 | — |
| Cheap | 45x | $277 | +86% |
| Fair | 136x | $835 | +459% |
| Expensive | 1,179x | $7,213 | +4732% |
Historical ranges are pointers, not guarantees.
PODD's PE is in its cheap range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings.
PODD Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for PODD, with profitability improving. However, they disagree widely on these estimates.
PODD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.52 | +23% |
| Q3 2026 | $6.12 | +78% |
| Q2 2026 | $5.33 | +63% |
| Q1 2026 | $4.28 | -23% |
| Q4 2025 | $3.48 | -40% |
| Q3 2025 | $3.44 | -41% |
| Q2 2025 | $3.28 | -41% |
| Q1 2025 | $5.55 | +67% |
| Q4 2024 | $5.78 | +97% |
PODD earned $6.12 per share over the past year, up 78% from the year before.
PODD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $842M | +19% |
| Q2 2026 | $801.7M | +24% |
| Q1 2026 | $761.7M | +34% |
| Q4 2025 | $783.8M | +31% |
| Q3 2025 | $706.3M | +30% |
| Q2 2025 | $649.1M | +33% |
| Q1 2025 | $569M | +29% |
| Q4 2024 | $597.5M | +17% |
PODD's revenue has grown year over year every quarter since late 2020: $842M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +5.9 points |
| Q2 2026 | 16% | -2.5 points |
| Q1 2026 | 16% | +0.4 points |
| Q4 2025 | 19% | +0.4 points |
| Q3 2025 | 17% | +0.5 points |
| Q2 2025 | 19% | +7.5 points |
| Q1 2025 | 16% | +2.7 points |
| Q4 2024 | 18% | -2.6 points |
PODD's operating margin was 23% last quarter, up 5.9 points from the same quarter a year ago, near the top of its range since 2019.
PODD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $66.4M | -34% |
| Q2 2026 | $55.9M | -69% |
| Q1 2026 | $89.5M | +74% |
| Q4 2025 | $48.2M | -49% |
| Q3 2025 | $100.1M | +39% |
| Q2 2025 | $177.9M | +140% |
| Q1 2025 | $51.5M | -21% |
| Q4 2024 | $94.1M | +492% |
PODD still generates free cash flow, though less than at its 2025 peak: $260M over the past year.
PODD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +89K shares |
| 1 year | -1.7% | -1.2M shares |
| 3 years | -5.6% | -4.1M shares |
| 5 years | -0.2% | -127K shares |
| Available history | +12% | +7.2M shares |
PODD has 69M diluted shares, down 1.7% from a year ago, with $300M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $300M |
| Q4 2025 | — |
| Q3 2025 | $29.5M |
PODD spent $300M buying back its own shares over the past year.
PODD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | 0.4x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.6x | Very low |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 1.1x | Healthy |
PODD's net debt is less than a year of its operating earnings (EBITDA).
PODD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.0 | Neutral |
| Stochastic | 48.9 | Neutral |
PODD's weekly RSI is 44 (neutral) and its Stochastic is 49 (neutral).
PODD PE vs Healthcare Sector
| Metric | PODD | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 26x | 5.6% below |
| PE % | 0 | 29 | 29 pts below |
PODD is trading at 24x earnings, in line with the Healthcare sector's median of 26x.
PODD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $142.3 | 4.9% above |
| 20 week MA | $147.8 | 1% above |
| 50 week MA | $191.3 | 22% below |
| 100 week MA | $243.7 | 39% below |
| 200 week MA | $234.4 | 36% below |
PODD has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 36% below its 200-week average.
PODD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $172.5 | $257.3 | +49% |
| 2021 | $257.3 | $273.3 | +6.2% |
| 2022 | $273.3 | $292.1 | +6.9% |
| 2023 | $292.1 | $217.0 | -26% |
| 2024 | $217.0 | $265.1 | +22% |
| 2025 | $265.1 | $288.6 | +8.9% |
| 2026 YTD | $288.6 | $149.3 | -48% |
PODD is down 48% so far in 2026, after finishing higher in five of the previous six years.